TRxADE GROUP, INC. Announces Uplisting to Nasdaq Capital Market, Pricing of $5.2 Million Firm Commitment Public Offering of Common Stock and Effectiveness of Reverse Stock Split
Stock Information for TRxADE HEALTH Inc.
Loading
Please wait while we load your information from QuoteMedia.